CD4 and neoplasm: The decline in the CD4+ T cell count might be explained by the sequestration of lymphocytes to the growing tumor, or by a lack of continuing T-cell recovery, which might result in a lack of EBV-specific CD4+ T cells, which are important for the immune surveillance of EBV-infection [79–83].